Artificial Intelligence for Gastroenterology Practice: A Modified Delphi Consensus
Recommended Citation
Gross SA, Shaukat A, Afzali A, Ahn JC, Bajaj JS, Barkin JA, Bilal M, Chawla S, Coelho-Prabhu N, Enslin SM, Feld AD, Gagneja HK, Hass DJ, Hernandez-Barco YG, Horst SN, Jacobson BC, Jones PD, Kaul V, Kushnir VM, Leggett CL, Leung G, Mascarenhas M, Parasa S, Parsa N, Schairer JN, Shah ED, Simonetto DA, Spiegel B, Stidham RW, Suthrum P, Thomas S, Phillips ME. Artificial Intelligence for Gastroenterology Practice: A Modified Delphi Consensus. Am J Gastroenterol. 2026.
Document Type
Article
Publication Date
2-10-2026
Publication Title
The American journal of gastroenterology
Keywords
adoption; artificial intelligence; consensus
Abstract
INTRODUCTION: The American College of Gastroenterology assembled a multidisciplinary task force to evaluate the current state and future direction of artificial intelligence (AI) in gastroenterology, hepatology, and endoscopy leading to the development of consensus-based recommendations for responsible AI integration in clinical practice.
METHODS: A total of 32 subject-matter experts and 12 industry partners, representing diverse practice settings and expertise, conducted subgroup literature reviews across 5 key areas (endoscopy, practice management clinical applications, training and education, inflammatory bowel disease and liver disease, ethics and equity). Draft statements were developed and rated on a 5-point Likert scale using a modified Delphi process. A consensus was set at ≥70% combined agreement. Nonconsensus items were revised and revoted electronically.
RESULTS: A total of 43 statements, 40 (93%) reached consensus in round 1 and the remaining 3 achieved consensus after round 2. Evidence supports computer-aided detection improving adenoma detection rate and miss rate in controlled studies, with mixed real-world impact and insufficient long-term outcomes (e.g., interval colon cancer rate). Recommendations emphasize thorough validation and reduction of bias by heterogeneous Data sets. Outside endoscopy, ambient AI scribes, natural language processing (NLP)-enabled coding, workflow optimization, and previous authorization support show potential. Training recommendations endorse a structured AI curriculum while preserving independent procedural competence to avoid deskilling. In inflammatory bowel disease and hepatology, AI could help improve diagnostic accuracy, help predict risk of disease progression, and help guide therapy. Equity, governance, and reimbursement statements call for chain-of-custody data protections, specialty-society oversight, and payment models that reward quality and cost reduction.
DISCUSSION: This consensus outlines how AI can augment rather than replace clinical expertise while promoting safety, transparency, interoperability, and equity. Priorities include pragmatic and prospective trials, multi-institutional data-sharing consortia, bias mitigation, and workforce training to enable trustworthy and clinically impactful AI adoption in gastroenterology, liver, and endoscopy care.
PubMed ID
41665234
ePublication
ePub ahead of print
